Evaluation of a biotin-based surrogate virus neutralization test for detecting postvaccination antibodies against SARS-CoV-2 variants in sera
Open Access
- 19 January 2023
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 646, 8-18
Abstract
No abstract availableKeywords
Funding Information
- Korea Research Institute of Bioscience and Biotechnology
- National Research Council of Science and Technology (CAP21061-100)
- National NanoFab Center
This publication has 19 references indexed in Scilit:
- SARS-CoV-2 serology testing: Progress and challengesJournal of Immunological Methods, 2021
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionNature Medicine, 2021
- Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)Diagnostic Microbiology and Infectious Disease, 2021
- A simple protein-based surrogate neutralization assay for SARS-CoV-2JCI Insight, 2020
- Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19Acta Pharmacologica Sinica, 2020
- A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interactionNature Biotechnology, 2020
- Complete Genome Sequence of a Novel Coronavirus (SARS-CoV-2) Isolate from BangladeshMicrobiology Resource Announcements, 2020
- The First Disease X is Caused by a Highly Transmissible Acute Respiratory Syndrome CoronavirusVirologica Sinica, 2020
- Pseudotype Neutralization Assays: From Laboratory Bench to Data AnalysisMethods and Protocols, 2018
- Statistics corner: A guide to appropriate use of correlation coefficient in medical research.2012